We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Vaccine Progress for Virus Behind “The Kissing Disease”

News   Apr 09, 2019 | Original story by the NIH/National Institute of Allergy and Infectious Diseases

 
Vaccine Progress for Virus Behind “The Kissing Disease”

This is a cryo-EM image of the gH/gL/gp45 candidate vaccine construct. Image credit: NIAID

 
 
 

RELATED ARTICLES

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News

In a new study, researchers have tested the binding specificity of commercial antibodies to the C9ORF72 protein, and explored a novel validation approach.

READ MORE

Will a Next-generation Therapy for Diabetes Soon Be Available?

News

In order to improve diabetes therapy, researchers at the University of Geneva (UNIGE), Switzerland, have identified a protein called S100A9 which, under certain conditions, seems to act as a blood sugar and lipid regulator while avoiding the most harmful side effects of insulin.

READ MORE

"Exhausted" T Cells Lose the Battle Against Disease

News

A new study has identified the molecular mechanisms behind which T cells will lose the battle against cancer earlier, which could inform treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE